NeuroBo Pharmaceuticals Inc

NASDAQ:NRBO   3:59:54 PM EDT
1.48
-0.04 (-2.63%)
4:17:41 PM EDT: $1.48 0.00 (0.00%)
Earnings Announcements

Neurobo Pharmaceuticals Reports 16 Cents Q3 Loss Per share

Published: 11/15/2021 13:24 GMT
NeuroBo Pharmaceuticals Inc (NRBO) - Neurobo Pharmaceuticals Reports Third Quarter 2021 Financial Results.
Q3 Loss per Share $0.16.
Expects Its Cash Position Will Be Adequate to Fund Operations Into Q4 of 2022.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.15

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.16

More details on our Analysts Page.